Distinct breast cancer incidence and prognostic patterns in the NCI's SEER program: suggesting a possible link between etiology and outcome
- PMID: 15803359
- DOI: 10.1007/s10549-004-3777-3
Distinct breast cancer incidence and prognostic patterns in the NCI's SEER program: suggesting a possible link between etiology and outcome
Abstract
Background: Breast cancer is a heterogeneous and chronic disease with relapses and death occurring 25 years or more after primary diagnosis. Standard tumor characteristics are used to predict initial relapse or death, but their ability to estimate long-term patterns of failure may be limited.
Methods: To further evaluate the significance of standard tumor features, we compared incidence and prognostic patterns in the National Cancer Institute's (NCI's) large-scale population-based Surveillance, Epidemiology, and End Results (SEER) program for high-risk versus low-risk breast cancers, i.e., size > 2.0 versus < or = 2.0 cm, lymph node positive versus negative, high versus low histologic grade, and hormone receptor negative versus positive expression, respectively. Data were stratified by age 50 years to approximate menopause.
Results: High-risk versus low-risk breast cancers demonstrated two very different incidence and prognostic patterns. Age-specific incidence rates among women with high-risk tumors increased until age 50 years then flattened, whereas rates among women with low-risk tumors increased continuously with aging. Hazard rates for breast cancer death spiked sharply two years following primary breast cancer diagnosis among women with high-risk but not with low-risk tumors. Paradoxically, hazard function crossed over 6-8 years following breast cancer diagnosis, with hazard rates lower for high-risk than for low-risk breast cancers.
Conclusion: Distinct incidence and prognostic patterns among high-risk and low-risk breast cancers suggest a possible link between breast cancer etiology and outcome. These epidemiologic results appear to complement emerging molecular genetic techniques, showing distinct genotypes for high-risk and low-risk breast cancer phenotypes.
Comment in
-
Comment to Anderson WF, Jatoi I, Devesa SS: distinct breast cancer incidence and prognostic patterns in the NCI'S SEER program: suggesting a possible link between etiology and outcome. Breast Cancer Res Treat 90:127-137, 2005.Breast Cancer Res Treat. 2006 Jun;97(3):341-3. doi: 10.1007/s10549-005-9128-1. Epub 2006 May 10. Breast Cancer Res Treat. 2006. PMID: 16791490 No abstract available.
Similar articles
-
Comment to Anderson WF, Jatoi I, Devesa SS: distinct breast cancer incidence and prognostic patterns in the NCI'S SEER program: suggesting a possible link between etiology and outcome. Breast Cancer Res Treat 90:127-137, 2005.Breast Cancer Res Treat. 2006 Jun;97(3):341-3. doi: 10.1007/s10549-005-9128-1. Epub 2006 May 10. Breast Cancer Res Treat. 2006. PMID: 16791490 No abstract available.
-
Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma.Cancer Epidemiol Biomarkers Prev. 2004 Jul;13(7):1128-35. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15247123
-
Inflammatory breast carcinoma and noninflammatory locally advanced breast carcinoma: distinct clinicopathologic entities?J Clin Oncol. 2003 Jun 15;21(12):2254-9. doi: 10.1200/JCO.2003.07.082. J Clin Oncol. 2003. PMID: 12805323
-
Prognosis and management of patients with node-negative invasive breast carcinoma that is 1 cm or smaller in size (stage 1; T1a,bN0M0): a review of the literature.J Clin Oncol. 2006 May 1;24(13):2113-22. doi: 10.1200/JCO.2005.02.8035. J Clin Oncol. 2006. PMID: 16648513 Review.
-
Breast cancer: geographic variation and risk factors.J Environ Pathol Toxicol Oncol. 1992 Sep-Oct;11(5-6):313-6. J Environ Pathol Toxicol Oncol. 1992. PMID: 1464813 Review.
Cited by
-
Letrozole as upfront endocrine therapy for postmenopausal women with hormone-sensitive breast cancer: BIG 1-98.Breast Cancer Res Treat. 2007;105 Suppl 1(Suppl 1):55-66. doi: 10.1007/s10549-007-9700-y. Epub 2007 Oct 3. Breast Cancer Res Treat. 2007. PMID: 17912636 Free PMC article. Clinical Trial.
-
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies.J Natl Cancer Inst. 2011 Feb 2;103(3):250-63. doi: 10.1093/jnci/djq526. Epub 2010 Dec 29. J Natl Cancer Inst. 2011. PMID: 21191117 Free PMC article.
-
Challenges in studying the etiology of breast cancer subtypes.Breast Cancer Res. 2009;11(3):104. doi: 10.1186/bcr2323. Epub 2009 Jun 29. Breast Cancer Res. 2009. PMID: 19635173 Free PMC article.
-
Coffee consumption and breast cancer risk: a narrative review in the general population and in different subtypes of breast cancer.Eur J Nutr. 2021 Apr;60(3):1197-1235. doi: 10.1007/s00394-020-02465-0. Epub 2021 Jan 13. Eur J Nutr. 2021. PMID: 33442757 Review.
-
A genome-wide association study of prognosis in breast cancer.Cancer Epidemiol Biomarkers Prev. 2010 Apr;19(4):1140-3. doi: 10.1158/1055-9965.EPI-10-0085. Epub 2010 Mar 23. Cancer Epidemiol Biomarkers Prev. 2010. PMID: 20332263 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical